170 related articles for article (PubMed ID: 18519412)
21. Primary extranodal non-Hodgkin's lymphoma: clinicopathological features, survival and treatment outcome in two cancer centers of southern Turkey.
Mertsoylu H; Muallaoglu S; Besen AA; Erdogdu S; Sezer A; Sedef AM; Kose F; Arican A; Ozyilkan O
Asian Pac J Cancer Prev; 2014; 15(17):7207-11. PubMed ID: 25227815
[TBL] [Abstract][Full Text] [Related]
22. [High-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma].
Provencio M; Fayad LE
Med Clin (Barc); 2008 Jan; 130(2):60-5. PubMed ID: 18221676
[No Abstract] [Full Text] [Related]
23. Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvement.
Chan KL; van der Weyden C; Khoo C; Lade S; Blombery P; Westerman D; Khot A; Melo B; Johnstone RW; Prince HM; Dickinson M
Leuk Lymphoma; 2017 Apr; 58(4):996-998. PubMed ID: 27558082
[No Abstract] [Full Text] [Related]
24. Do You Know Pixantrone?
Minotti G; Menna P; Salvatorelli E
Chemotherapy; 2017; 62(3):192-193. PubMed ID: 28334703
[No Abstract] [Full Text] [Related]
25. Advances in chemotherapy for large cell lymphoma.
Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW
Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781
[TBL] [Abstract][Full Text] [Related]
26. [Non-Hodgkin's lymphoma. Results of a therapeutic protocol].
Verdeguer A; Castel V; Mínguez JR; Ferris J
An Esp Pediatr; 1988 Oct; 29 Suppl 34():130-2. PubMed ID: 3214020
[No Abstract] [Full Text] [Related]
27. Relapse of primary CNS lymphoma after more than 10 years in complete remission.
Herrlinger U; Hebart H; Kanz L; Dichgans J; Weller M
J Neurol; 2005 Nov; 252(11):1409-10. PubMed ID: 15895304
[No Abstract] [Full Text] [Related]
28. Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients.
Todeschini G; Ambrosetti A; Meneghini V; Pizzolo G; Menestrina F; Chilosi M; Benedetti F; Veneri D; Cetto GL; Perona G
J Clin Oncol; 1990 May; 8(5):804-8. PubMed ID: 1692089
[TBL] [Abstract][Full Text] [Related]
29. Clinical investigations in aggressive non-Hodgkin lymphoma.
Jonathan F
Clin Adv Hematol Oncol; 2008 Sep; 6(9):7-8. PubMed ID: 18998259
[No Abstract] [Full Text] [Related]
30. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
[TBL] [Abstract][Full Text] [Related]
31. [Anatomopathological and clinical aspects of primary gastric lymphoma].
Faraone V; Bartolo V; Calogero G; Maglitto D; La Malfa G; Briguglio M; Palmisano M; Di Mauro F
Ann Ital Chir; 1994; 65(1):75-9; discussion 80. PubMed ID: 7978750
[TBL] [Abstract][Full Text] [Related]
32. A weekly alternating chemotherapy regimen with low toxicity for the treatment of aggressive lymphoma.
Bower M; Brock C; Gulliford T; O'Reilly SM; Smith DB; Newlands ES
Cancer Chemother Pharmacol; 1996; 38(1):106-9. PubMed ID: 8603443
[TBL] [Abstract][Full Text] [Related]
33. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
34. New therapeutic approaches to non-Hodgkin's lymphomas.
Lambert JF; Elfenbein GJ
Med Health R I; 2003 Aug; 86(8):236-9. PubMed ID: 14582217
[No Abstract] [Full Text] [Related]
35. Primary central nervous system lymphoma with testicular relapse.
Harney J; Pope A; Short SC
Clin Oncol (R Coll Radiol); 2004 May; 16(3):193-5. PubMed ID: 15191006
[TBL] [Abstract][Full Text] [Related]
36. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
Gordon LI; Harrington D; Andersen J; Colgan J; Glick J; Neiman R; Mann R; Resnick GD; Barcos M; Gottlieb A
N Engl J Med; 1992 Nov; 327(19):1342-9. PubMed ID: 1383819
[TBL] [Abstract][Full Text] [Related]
37. [Primary pulmonary Non-Hodgkin's lymphoma: report of a case].
Ouarssani A; Atoini F; Lhou FA; Rguibi MI
Pan Afr Med J; 2012; 11():56. PubMed ID: 22593792
[TBL] [Abstract][Full Text] [Related]
38. Myeloablation for lymphoma--question answered?
Milpied N
N Engl J Med; 2013 Oct; 369(18):1750-1. PubMed ID: 24171521
[No Abstract] [Full Text] [Related]
39. [A three-year experience with use of mabthera (rituximab) in treatment of indolent non-Hodgkin's disease refractory to standard chemotherapy].
Korolenko VO; Gershanovich ML; Tikhonova VV
Vopr Onkol; 2004; 50(4):421-5. PubMed ID: 15605764
[No Abstract] [Full Text] [Related]
40. Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy.
Touroutoglou N; Dimopoulos MA; Younes A; Hess M; Pugh W; Cox J; Cabanillas F; Sarris AH
J Clin Oncol; 1995 Jun; 13(6):1361-7. PubMed ID: 7751880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
